Latest Shareholder Value News

Page 42 of 286
Cash Converters International Limited reported an 8% rise in half-year revenue to $206.7 million, driven by franchise acquisitions and a shift in lending strategy. Despite a 17% dip in net profit due to one-off costs, the company declared a fully franked interim dividend and reinstated its Dividend Reinvestment Plan.
Claire Turing
Claire Turing
23 Feb 2026
Genesis Energy has reported a record first-half normalised EBITDAF of NZ$307 million, underpinned by strong hydro inflows and portfolio flexibility, while announcing a $400 million equity raise to accelerate its renewable growth strategy.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Cash Converters International Limited has announced the recommencement of its Dividend Reinvestment Plan (DRP) effective 20 February 2026, restoring shareholders’ ability to reinvest dividends into additional shares with favourable terms.
Claire Turing
Claire Turing
20 Feb 2026
3D Energi Limited remains suspended from ASX trading after failing to provide a crucial update on its funding status and exploration permit implications, prolonging market uncertainty.
Maxwell Dee
Maxwell Dee
20 Feb 2026
N1 Holdings Limited reported a robust 64.7% increase in net profit after tax to $1.04 million for the half-year ended December 2025, driven by strong commercial lending growth and operational efficiencies. The company also expanded its committed lending capacity to over $355 million while maintaining a stable dividend.
Claire Turing
Claire Turing
20 Feb 2026
Cadence Opportunities Fund Limited has reported a remarkable turnaround for the half-year ending December 2025, posting a $6.4 million profit and raising its interim dividend to 7.5 cents per share.
Claire Turing
Claire Turing
20 Feb 2026
Cadence Capital Limited has reported a remarkable turnaround with a 508% surge in profit after tax for the half-year ended December 2025, alongside a fully franked interim dividend declaration.
Claire Turing
Claire Turing
20 Feb 2026
Murray Cod Australia has appointed Steven Chaur as its new Managing Director and CEO, aiming to accelerate revenue growth and operational efficiency from April 2026. The move signals a strategic push to deepen domestic channels and expand the luxury fish brand’s market presence.
Ada Torres
Ada Torres
20 Feb 2026
Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.
Ada Torres
Ada Torres
20 Feb 2026
L1 Long Short Fund Limited has reported a robust turnaround with a $415 million net profit for the half-year ending December 2025, declaring a fully franked interim dividend of 3.6 cents per share.
Claire Turing
Claire Turing
20 Feb 2026
MyState Limited reported a robust half-year result with a 61% rise in underlying net profit, driven by the full impact of its Auswide Bank merger and strong growth across key business lines. The company also declared a fully franked interim dividend of 12 cents per share.
Claire Turing
Claire Turing
20 Feb 2026
Boom Logistics has reported a record half-year revenue of $142.2 million for 1H FY26, alongside upgraded earnings guidance and an expanded share buy-back program, signalling strong operational momentum despite sector challenges.
Maxwell Dee
Maxwell Dee
20 Feb 2026